View Profile

Vusumuzi Ngonidzashe Hove

Scientific Researcher, Pharmaceutical Sciences and Medicinal Chemistry · University at Buffalo

https://researchid.co/vuvuhove
@vusumuzihove
1Scopus Publications
16Google Scholar Citations
1Google Scholar h-index
1Google Scholar i10-index

Research Interests

Medicinal Chemistry, PK/PD modeling, Cancer Research

Biography

Vusumuzi Ngonidzashe Hove is a medicinal chemistry researcher and pharmaceutical scientist with a focus on clinical oncology. His research involves investigating the therapeutic efficacy, ADME properties, and toxicity of pharmacologic agents (in vitro and in vivo) using pharmacokinetic/pharmacodynamic (PK/PD) modeling. Another aspect of his work includes identifying clinically relevant drug-drug interactions (DDIs) to inform future regulatory studies on drug disposition. Additionally, he has explored the use of oxime ligands for Fe(III) MRI contrast agents and for sensing Fe(III) and Fe(II). Hove pursued his undergraduate and graduate studies at the University at Buffalo, earning a Bachelor’s degree in Chemistry and two Master of Science degrees in Medicinal Chemistry and Pharmaceutical Sciences. He was awarded the Professor Emeritus Dr. Thomas J. Bardos Scholarship, presented by the University at Buffalo School of Pharmacy and Pharmaceutical Sciences.

Education

• St. George's College, Harare, Zimbabwe (2003-2008) • Bachelor’s Degree in Chemistry (Cum Laude with Distinction) (2010-2014), University at Buffalo, Department of Chemistry • Master of Science (MS) Degree in Medicinal and Pharmaceutical Chemistry (2016-2019), University at Buffalo, Department of Chemistry • Master of Science (MS) Degree in Pharmaceutical Sciences (2019-2023), The University at Buffalo School of Pharmacy and Pharmaceutical Sciences • Ph.D. Degree in Pharmaceutical Sciences (2019-present), The University at Buffalo School of Pharmacy and Pharmaceutical Sciences

Recent Scopus Publications

  1. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake
    Molecular Pharmacology, 2022

Links